Scinovex
article Open AccessTop 1% cited

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Clinical Infectious Diseases · 2020 · Vol. 71(15) · pp. 762–768
Chuan QinLuo‐Qi ZhouZiwei HuShuoqi ZhangSheng YangTao YuCuihong XieKe MaKe ShangWei WangDai‐Shi Tian

Abstract

The novel coronavirus might mainly act on lymphocytes, especially T lymphocytes. Surveillance of NLR and lymphocyte subsets is helpful in the early screening of critical illness, diagnosis, and treatment of COVID-19.

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchMedicinemyalgiaLymphocyteImmunologyCoronavirus disease 2019 (COVID-19)Internal medicineImmune systemSeverity of illnessGastroenterologyDisease

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2AdultAgedAged, 80 and overChinaCoughFemaleFeverHospitalizationHumansLeukocyte CountLymphocytesMale
Citations
4,996
FWCI
115.39
field-weighted impact
References
18
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.